All the 60% market share and the inventory of Baiyunshan, a Banlangen production enterprise, have been zero for a long time. Tongrentang set up a special leading group to stop its drug production, and instead fully organized the production of Banlangen Qingre Jiedu Oral Liquid. Huabei Pharmaceutical increased its efforts in ribavirin.
The production of new antiviral drugs involves the production of ribavirin raw materials such as Xinghu Technology, Livzon Group, Lu Kang Medicine and Baiyun Mountain, and the sales of related products of Huabei Pharmaceutical, Qianjiang Pharmaceutical, Shuanghe Pharmaceutical, Lu Kang Pharmaceutical, Northern Pharmaceutical and other companies have soared.
Extended data
Sales management:
There are 9 products whose income exceeds 1 100 million yuan, and 4 products whose joint venture company exceeds 100 million yuan, including 3 compound Danshen tablets. 5.7 billion yuan, Banlangen and medium and long chain fat emulsion injection 204 million yuan.
Wohua Pharmaceutical Company's Sanqi Pills, Hong Ju Pills, Buzhong Yiqi Pills, Banlangen Granules, Yinqiao Jiedu Pills, Yinqiao Jiedu Tablets, Fangfeng Tongsheng Pills, Huoxiang Zhengqi Water, Niuhuang Jiedu Pills and Niuhuang Jiedu Tablets.
Twenty-five kinds of Chinese medicines, including Niuhuang Shangqing Pill, Liuwei Dihuang Pill, Fuzi Lizhong Pill, Xuan Tong Li Fei Pill, Shedan Chuanbei Liquid, Shen Ling Baizhu Pill, Xiangsha Liu Jun Pill, Guipi Pill, Tianwang Buxin Pill, Huaijiao Pill, Xiaoyao Pill and Aifu Nuangong Pill, have been listed in the national list of essential drugs.